Once manufacturers understand how government drug pricing programs and external factors interact with pricing strategies with VA FSS, the next step is mastering Non-FAMP and FCP calculations. Using practical examples, speakers will guide participants through best practices for:

• Discovering the formula for Non-FAMP and FCP calculations under VHCA Section 603
  • When must these calculations be reported to the VA?
• Applying the correct formula for calculating FCP and Non-FAMP
• Establishing best practices for sourcing and managing pricing data
  • Identifying which transactions and price concessions must be included in Non-FAMP calculations
  • Addressing data gaps and ensuring accuracy in reporting
• Navigating complexities and anomalies in Non-FAMP calculations
  • Handling “smoothing” methodologies and outliers
  • Rules for new and transferred products
• Reviewing Dear Manufacturer Letters for insights on VA’s evolving interpretation of Non-FAMP calculations
• Determining when and how the Price Reductions Clauses (PRC) apply to VA contracts